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than the three test protocols (P , 0.005). Finally, the nadirPreventing dialysis hypotension: A comparison of usual protec-
mean arterial pressures were significantly lower in the standardtive maneuvers.
and isolated ultrafiltration protocols when compared with theBackground. Intradialytic hypotension (IH) is a common
three test protocols (P , 0.05). The upright postdialysis bloodadverse event. Currently, there are several commonly utilized
pressure was best preserved in the sodium modeling and cooltherapies of IH, but they have not been compared directly in
the same group of patients. We performed the present study temperature protocols compared with the standard and iso-
in order to learn which of these techniques is most effective lated ultrafiltration protocols (P , 0.05).
so that a rational approach to treating IH could then be formu- Conclusion. This study supports the use of sodium modeling
lated. as a first step in combating IH. Also effective were the use of
Methods. A single-blinded, crossover study design of five cool-temperature dialysate and a high-sodium dialysate. All
different protocols was undertaken in 10 hemodialysis patients three test protocols were well tolerated. As applied in this
with a prior history of IH. Each patient first underwent one study, isolated ultrafiltration followed by isovolemic dialysis
week (three dialyses) of standard dialysis (dialysate sodium was notably less effective in reducing IH.
138 mEq/L). Then each patient was subjected to one week
each (three dialyses) of the four test protocols, performed in
random order in a blinded fashion. The specific protocols were
Intradialytic hypotension (IH) is a common adverseas follows: high sodium dialysate, in which the patient was
dialyzed using a dialysate sodium of 144 mEq/L; sodium model- event that occurs in 15 to 25% of all dialysis treatments
ing, during which the dialysate sodium declined from 152 to [1, 2]. Hypotension is a major clinical problem not only
140 mEq/L in the last half hour of dialysis; one hour of isolated because of its frequency, but also because it contributesultrafiltration followed by three hours of isovolemic dialysis;
to the unwell feelings experienced by dialysis patients,and cool temperature dialysis in which the dialysate was cooled
limits rehabilitation, and consumes a disproportionateto 358C.
Results. Weight loss in each of the five protocols was essen- amount of dialysis staff time and resources. Dialysis hy-
tially identical, varying between 2.9 and 3 kg. There were sig- potension has a multifactorial etiology, including such
nificantly fewer hypotensive episodes per treatment in the so-
disparate causes as autonomic, dysfunction [3–8], de-dium modeling, high sodium, and cool temperature protocols as
creased plasma osmolality [9, 10], a decrease in extracel-compared with the standard protocol (P , 0.05). Ultrafiltration
followed by dialysis was associated with a significantly greater lular fluid volume with inadequate plasma [11], impaired
number of hypotensive episodes per treatment than any of the venous compliance [12], decreased cardiac reserve [13],
three test protocols (P , 0.05). Similarly, the number of nursing changes in serum potassium and calcium concentrations,interventions required for IH per treatment was significantly
and, perhaps, an accumulation of nitric oxide [14–16].greater in the standard dialysis and in the isolated ultrafiltration
There are several commonly utilized therapies of dial-protocols compared with sodium modeling and cool tempera-
ture protocols (P , 0.05). The number of hypotensive signs ysis hypotension, and each of these has been developed
and symptoms per treatment was also significantly reduced to counter the specific derangements that lead to the
during the sodium modeling and cool temperature protocols
disorder. Thus, an increase in plasma osmolality has beencompared with the standard protocol (P , 0.004 and P ,
achieved by the use of either a high-sodium dialysate0.02, respectively). Again, the isolated ultrafiltration protocol
resulted in significantly more hypotensive symptoms and signs [17] or a sodium modeling protocol [18]. Cooling the
dialysate to 358C (from the usual 378C) induces catechol-
amine release and thereby leads to peripheral vasocon-Key words: hemodialysis, sodium modeling, cool temperature dialysis,
ultrafiltration, intradialytic hypotension. striction and an increase in cardiac inotropy [19, 20].
Isolated ultrafiltration followed by isovolemic dialysisReceived for publication January 20, 2000
enhances plasma refilling and maintains a steady plasmaand in revised form August 15, 2000
Accepted for publication October 9, 2000 osmolality [21]. Each of these strategies has been at
least partly successful in preventing dialysis hypotensionÓ 2001 by the International Society of Nephrology
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Table 1. Patient characteristics
Cause of Length of time on
Patient Number Age years Sex ESRD hemodialysis months
1 27 Female Chronic GN 112
2 51 Male Diabetes 38
3 67 Female Diabetes 25
4 68 Female Diabetes 24
5 79 Male Diabetes 36
6 68 Female Diabetes 24
7 84 Male Unknown 24
8 54 Female Diabetes 11
9 63 Female Diabetes 29
10 50 Female Diabetes 21
Mean6SEM 61.1612.5 30% Male 34.4616.6
70% Female
[17–21]. However, currently there is not a consensus unchanged in dose or frequency during the study; Table
among practitioners as to which of these strategies is 2 depicts the medicines consumed by the patient group.
most effective, in part because a direct comparison of
Experimental protocolthese maneuvers has not been performed previously.
Thus, in order to learn which of the techniques is most A single-blinded, crossover design of five different
effective as a therapy for IH, we performed the present dialysis protocols was undertaken in this study. Each
study to learn whether there was an advantage of one patient began the study by undergoing a standard dialysis
particular therapy versus another so that a rational ap- with a sodium bath of 138 mEq/L. The patient underwent
proach to therapy could be elucidated. one week (three dialysis sessions) of standard dialysis.
Following the completion of this week, each patient then
was subjected to one week each (three dialyses) of theMETHODS
four test protocols performed in random order in a
Patients
blinded fashion. Data were collected on all dialyses dur-
Informed consent was obtained from all patients, and ing the week. The ultrafiltration followed by dialysis
the protocol was approved by the Institutional Review protocol required several adjustments of the dialysis ma-
Board at the Medical College of Ohio. A total of 10 chine at the one-hour mark, and this made “blinding”
patients was recruited from the outpatient hemodialysis the patients impractical for this particular maneuver. The
facility at the Medical College of Ohio; inclusion criteria specific test protocols were as follows: High sodium dialy-
were that the patient had to have suffered frequent bouts sate in which the patient was dialyzed using a dialysate
of hypotension (four episodes per week or one or more sodium of 144 mEq/L; sodium modeling (step function
episodes of hypotension in .75% of treatments) during design) during which the dialysate sodium was 152
dialysis despite standard adjustments in dry weight and mEq/L at the onset of dialysis and then declined to 140
changes in antihypertensive medicine that would be ini- mEq/L in the last 30 minutes of dialysis; ultrafiltration
tially instituted to treat the problem. In most dialysis (one hour of isolated ultrafiltration in which 50% of the
units, dry weight is clinically determined and is defined target weight loss was removed not to exceed a total of
as the lowest weight a patient can tolerate without the
1.5 kg) followed by three hours of isovolemic dialysis;development of intradialytic symptoms (for example,
and cool-temperature dialysis in which the dialysate wascramping, nausea, vomiting, or lightheadedness) and hy-
cooled to 358C. The dialysate sodium concentration waspotension in the absence of overt fluid overload. In the
140 mEq/L in the cool-temperature protocol. During thestudy cohort, dry weight was increased, but there was
ultrafiltration followed by isovolemic dialysis protocol,no change in frequency of hypotensive episodes in these
all patients underwent three hours of dialysis in addition10 patients. Patients were excluded if they had uncon-
to the first hour of ultrafiltration only. Thus, for patientstrolled hypertension, unstable angina, a history of non-
on 3.5 or 4.0 hours of dialysis, this was less dialysis timecompliance, variable weight gains, or if they required
than usual.frequent hospitalization. The patients’ clinical character-
Other aspects of each of the dialysis treatments suchistics are shown in Table 1. As can be seen, 7 of the 10
as the dialysate composition (other than the sodium con-patients were women, and the average age was 61 years
centration), the quantity of dialysis, and the duration of(range 27 to 84 years). The population was dominated
dialysis were comparable in each of the protocols. Theby diabetics (8 of the 10 patients), and they had spent a
standard dialysate potassium was 2.0 mEq/L in nine oftotal of an average of 34.4 months on dialysis (range 11
to 112 months). The patient’s usual medications were the patients and 3.0 mEq/L in one patient; the dialysate
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Table 2. Patient medications
Patient
Number Antihypertensive/anti-anginal medications Other medications
1 None Phenytoin, conjugated estrogens, levothyroxine, bromocriptine, warfarin,
cisapride
2 Isosorbide mononitrate 60 mg qhs Testosterone IM, salmeterol, albuterol, ipratropium, ASA, ranitidine,
cisapride
3 Enalapril 15 mg qhs Amiodarone, levothyroxine, warfarin, insulin
4 Isosorbide dinitrate 10 mg tid, Hydralazine 50 mg ASA, warfarin, albuterol, hydroxyzine
tid, Metoprolol 50 mg bid
5 Amlodipine 10 mg qd Famotidine, ASA, simethicone
6 Amlodipine 5 mg qd, TTS#3 Insulin, quinine
7 None Dipyrimadole
8 None Insulin
9 Isosorbide dinitrate 10 mg tid, Atenolol 25 mg qd Metoclopramide, coated ASA, insulin
10 None Carbamazepine, conjugated estrogens, warfarin, cisapride, omeprazole, insulin
calcium concentration was 3.0 mEq/L, and the dialysate characterized by an abrupt .40 mm Hg decline in SBP.
These were not serial decrements in blood pressure overbicarbonate concentration was 35 mEq/L in all patients.
In addition, the same amount of weight was removed in the course of an entire treatment. Rather, in the majority
of cases the SBP had fallen to 100 mm Hg or there waseach of the protocols. Studies in which there was .0.6 kg
intraindividual weight variance in weight removal were a 60 mm Hg drop in SBP and/or 30 mm Hg drop in
DBP. Of these 64 episodes, 20 (31%) were accompaniedconsidered experimental failures and were not analyzed.
Food intake was not allowed during any of the maneu- by symptoms. Another 47 occurrences (36% of the total)
were IH due to a SBP ,100 mm Hg accompanied byvers. The temperature of the dialysate and the sodium
concentration of the dialysate were verified to insure symptoms. Finally, 20 of the 131 (15%) episodes of IH
were characterized by a blood pressure decline accompa-that the desired sodium concentration and dialysate tem-
perature were actually being delivered. In the sodium nied by adverse patient symptoms.
Orthostatic blood pressure recordings were obtainedmodeling program, the dialysate sodium concentration
was sampled twice, once at the beginning of dialysis and predialysis and postdialysis as follows: The patient was
placed in the supine position, and the access was cannu-then again in the last 20 minutes of dialysis to document
that the dialysate sodium had, in fact, decreased from lated. The patient remained in the supine position for
two minutes, after which a blood pressure and pulse were152 to 140 mEq/L. Hemoglobin and hematocrit measure-
ments and the urea reduction ratio were measured in recorded. Following this, the patient was asked to stand
or, if unable, to sit upright for two minutes, at whicheach patient weekly to make certain that these parame-
ters had not changed. The identical dialysis machine time another blood pressure and pulse were obtained.
The same procedure was performed following the dial-(Fresenius USA, Inc., Walnut Creek, CA, USA) and a
polysulfone dialyzer membrane (Fresenius F-80) were ysis after the patient had been disconnected from the
dialysis machine but still had the dialysis fistula cannu-used in all maneuvers. The dialysate flow rate was 500
mL/min for all of the patients, and the blood flow rates lated. In addition to the predialysis and postdialysis su-
pine and upright blood pressures and heart rates, thewere adjusted individually to achieve the usual prescrip-
tion for each patient (range 250 to 450 mL/min). The number of hypotensive episodes per treatment (defined
as mentioned previously in this article), the number ofblood pressure was recorded by an automated cuff every
15 minutes. nursing interventions required (data obtained from the
dialysis record), and the lowest blood pressure during aIntradialytic hypotension (IH) was defined as an
abrupt (over 10 to 15 min) decrement in blood pressure treatment were recorded. Nursing interventions included
the implementation of the routine maneuvers employedaccompanied by symptoms or a decline of blood pressure
requiring a nursing intervention. In addition, an abrupt by the nursing staff to combat dialysis hypotension.
These included placing the patient in the Trendelenbergdecrement (again, over 10 to 15 min) of greater than 40
mm Hg in systolic blood pressure (SBP) or greater than position, saline and hyperoncotic albumin boluses, de-
creasing the transmembrane ultrafiltration pressure, and20 mm Hg in diastolic blood pressure (DBP) was consid-
ered a significant intradialytic hypotensive change. Fi- early termination of treatment. All patient symptoms
of hypotension during dialysis were also recorded andnally, a SBP of less than 100 mm Hg or a DBP of less
than 40 mm Hg accompanied by symptoms was also included nausea, vomiting, sweating, dizziness, weak-
ness, and cramping. The patients were also questionedconsidered as hypotension. In this study, a total of 131
episodes of IH were recorded; 64 of these (49%) were during each of the treatments for any adverse symptoms
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Fig. 1. (A) Number of episodes of hypoten-
sion per dialysis treatment. Note the signifi-
cant reduction in hypotensive episodes with
the HNa, NaM, and 358C procedures. *.HNa,
NaM, and 358C, P , 0.05. (B) The number of
hypotensive events for each individual during
each of the maneuvers. Abbreviations are:
STD, standard; HNa, high-sodium dialysis;
NaM, sodium modeling; UF, ultrafiltration
followed by isovolemic dialysis; and 358C,
cooler temperature dialysis. All data in this
and the other figures are mean 6 SEM.
related to the therapeutic maneuvers such as excessive sodium modeling protocol, the initial sodium concentra-
thirst or shivering. The mean arterial pressure in this tion was 152 6 1.2 mEq/L, and the ending dialysis sodium
study was calculated as 1/3 3 (SBP 2 DBP) 1 DBP. concentration was 139 6 1.8 mEq/L. In the high-sodium
dialysate protocol, the mean dialysate sodium concentra-
Data analysis tion was 144 6 1.4 mEq/L. The dialysate temperature
For each of the five experimental protocols in the in the cool-temperature dialysis protocols was 358C.
patients, there were three hemodialysis treatments to
Changes in weight during the dialysis protocolsanalyze. Comparisons of values between dialysis sessions
were performed by repeated-measures analysis of vari- As by design, the changes in absolute weight loss
ance (ANOVA), and a P , 0.05 was considered signifi- achieved during each of the protocols was essentially
cant. The data are expressed as the mean 6 SEM. identical and varied between 2.9 and 3.0 kg. Similarly,
the percentage weight loss in each of the protocols was
between 3.7 and 3.8% for each of the protocols. Thus,RESULTS
each patient was subjected to an equivalent amount ofChanges in urea reduction ratio and hemoglobin
volume depletion during each of these protocols.concentration during each protocol
There were no significant differences in the urea re- Number of hypotensive episodes, frequency of nursing
duction ratio between any of the protocols. The urea interventions, and hypotensive signs and symptoms
reduction ratio range was 71 6 5% (in the cooler temper- during each of the protocols
ature and ultrafiltration protocols) to 78 6 5% (in the
The number of hypotensive episodes per treatmenthigh-sodium protocol). Similarly, the hemoglobin con-
for each of the five dialysis maneuvers is shown in Figurecentrations ranged between 10 and 10.5 g/dL in each of
1A. As can be seen from Figure 1, there were significantlythe protocols and were also not significantly different
fewer hypotensive episodes per treatment when the pa-between maneuvers.
tients were dialyzed on the high-sodium, sodium-model-
Delivered dialysate sodium and verification of ing, and cool-temperature dialysis protocol as compared
cool-temperature dialysis with the standard bath. In contrast, the ultrafiltration
followed by dialysis protocol was associated with a sig-In the standard dialysis protocol, the measured dialy-
sate sodium concentration was 138 6 1.2 mEq/L. In the nificantly greater number of episodes of hypotension
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Fig. 2. Number of nursing interventions per treatment for all five proto-
cols. The NaM and 358C procedures required significantly fewer inter- Fig. 3. Hypotensive symptoms and signs per dialysis treatment. A sig-ventions than the other maneuvers. Abbreviations are: HNa, high- nificant reduction in hypotensive symptoms and signs was noted in thesodium dialysis; NaM, sodium modeling; UF, ultrafiltration followed NaM and 358C protocols as compared with the other maneuvers. Abbrevi-by isovolemic dialysis; and 358C, cooler temperature dialysis. *.358C, ations are: HNa, high-sodium dialysis; NaM, sodium modeling; UF,P , 0.05; .NaM, P , 0.01. ultrafiltration followed by isovolemic dialysis; and 358C, cooler tempera-
ture dialysis. *.358C, P , 0.02; .NaM, P , 0.004.
than any of the three test protocols. Figure 1B depicts
each individual patient’s number of hypotensive epi-
DISCUSSIONsodes during each of the protocols. Similarly, as shown
In this population of hypotension-prone patients, thein Figure 2, the number of nursing interventions required
results of this direct comparison of maneuvers commonlyper treatment was significantly greater in the standard
dialysis protocol and in the ultrafiltration protocol when used to treat dialysis hypotension show that sodium mod-
compared with the sodium modeling and cool-tempera- eling using a step-wise protocol and cooler temperature
ture protocols. Finally, as shown in Figure 3, the number dialysate is most effective in stabilizing blood pressure
of hypotensive symptoms and signs per treatment was throughout the dialysis procedure. The results also dem-
also significantly reduced during the sodium-modeling onstrate significant hemodynamic benefits of a higher
and 358C protocols as compared with the standard bath. sodium dialysate concentration (144 mEq/L). Surpris-
Again, the ultrafiltration protocol resulted in signifi- ingly, the popular procedure of performing isolated ul-
cantly more hypotensive signs and symptoms than the trafiltration followed by dialysis proved to be ineffective
three test protocols. This reduction in the number of in preventing the occurrence of dialysis hypotension, and
hypotensive symptoms and signs was particularly notable was also associated with hypotensive symptoms and signs
in the sodium-modeling protocol in which no adverse more frequently than might have been expected. It
symptoms or signs were recorded during the study. should be acknowledged that the isolated ultrafiltration
followed by isovolemic dialysis procedure was designedChanges in blood pressure during each protocol
to remove 50% of the goal weight loss in the first hour
As shown in Table 3, the mean blood pressure in the of dialysis (not to exceed a total of 1.5 kg). This amount
upright position postdialysis was lower in the standard of volume reduction in one hour may be excessive for
and ultrafiltration procedures. The upright postdialysis some patients. However, it is common for patients to
blood pressure was best preserved in the sodium-model- have weight loss requirements in excess of the amount
ing and cooler temperature dialysis protocols. Interest-
removed in this group of hypotension-prone patients soingly, the high-sodium dialysis procedure was associated
that the protocol design is reflective of the circumstanceswith a lower upright postdialysis blood pressure than
that occur in usual dialysis practice.sodium modeling or cooler temperature despite the fact
In the last several years, there have been a numberthat there was a similar reduction in the number of hypo-
of studies that have addressed the etiology of dialysistensive events observed in the high-sodium, sodium-
hypotension and sought remedies to reduce its frequencymodeling, and cooler temperature procedures (Fig. 1).
and severity. Dialysis hypotension usually presents inThe nadir in arterial pressure in the five protocols was
one of two ways: as episodic hypotension in which aalso significantly lower in the standard and ultrafiltration
sharp fall in the blood pressure (usually later in dialysis)followed by dialysis procedures. The nadir blood pres-
accompanied by signs and symptoms of hypotension aresure was 64 6 8 mm Hg in the standard dialysis procedure
noted, and chronic, persistent hypotension in which theand 66 6 8 mm Hg in the ultrafiltration procedure. The
SBP is less than 90 to 100 mm Hg at the initiation ofnadir blood pressure was 80 6 14 mm Hg in sodium
dialysis. The latter condition is characterized by highmodeling, 72 6 9 mm Hg in high-sodium dialysis, and
circulating angiotensin II levels and maximal vasocon-76 6 11 mm Hg in cool-temperature dialysis. The nadir
striction predialysis [22, 23] and is more commonly recog-blood pressures were significantly lower (P , 0.05) in
nized in individuals who have been on dialysis for athe standard and ultrafiltration protocols as compared
with the other three maneuvers. number of years. Both of these conditions are therapeu-
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Table 3. Mean supine to upright blood pressures pre- and post-hemodialysis for the five protocols
Supine MAP Upright MAP Supine MAP Upright MAP
pre-HD Pre-HD Post-HD Post-HD
mm Hg
Standard 100615 101613 88611 7869a
HNa 99612 102611 9266 8068a
NaM 99613 104613 94611 9169
UF 98615 100614 86610 8068a
358C 102612 102613 9469 86611
Abbreviations are: HNa, high sodium; NaM, sodium modeling; UF, ultrafiltration followed by dialysis; 358C, cool temperature dialysis; MAP, mean arterial pressure.
a ,NaM and 358C protocols, P , 0.05
tic challenges because ultrafiltration requirements are of the procedure [28, 29]. Hence, in the present study,
we selected a step-wise pattern of sodium modeling withdifficult to achieve in the context of hemodynamic insta-
bility. Hemodynamic instability is particularly trouble- the higher sodium dialysate concentration at the initia-
tion of the procedure. Of note is the fact that not allsome because it contributes to the morbidity associated
with dialysis. Patients who are frequently hypotensive work has supported the use of sodium modeling as best
tolerated by patients. In one recent study, even thoughoften feel unwell and spend the interdialytic period “re-
covering” from the preceding dialysis. In addition, such blood pressure was well supported during sodium model-
ing protocols, patients complained of excessive thirst inpatients often have their dialysis procedure interrupted
with delays that result in a decrease in the dialysis pre- the interdialytic period [29].
This study was designed to learn which of several com-scription. If dialysis hypotension occurs frequently, the
patient may be chronically underdialyzed, and this may monly employed protective maneuvers was most effec-
tive in a population of patients in whom dialysis hypoten-result in a further increase in morbidity and mortality
[24, 25]. Chronic persistent hypotension is estimated to sion was frequent and disabling. Physicians and dialysis
units familiar with this syndrome typically have devel-occur in 3 to 5% of the dialysis population, whereas
episodic hypotension occurs in between 15 and 25% of oped individual algorithms used to treat dialysis hypo-
tension, and the aim of the study was to provide insightall dialysis encounters [22].
Episodic hypotension has multiple etiologies. Several into which of the procedures is actually most effective
when tested under rigorous conditions. The results sup-studies have shown that a fall in plasma osmolality as
ultrafiltration proceeds compounds extracellular volume port the use of sodium modeling as a first step in combat-
ing dialysis hypotension. As noted previously in this arti-depletion because fluid moves intracellularly. This has
led to the routine use of a higher sodium dialysate con- cle, the tolerance of patients to sodium modeling may be
idiosyncratic, and therefore, it should not be surprising ifcentration (140 to 144 mEq/L) with reported favorable
outcomes [26]. Moreover, the use of a higher sodium all individuals are unable to tolerate a modeling protocol
routinely. In this study, sodium modeling was well toler-dialysate has been shown to be safe, although it does
increase thirst and results in higher interdialytic weight ated, with most patients (6 out of 10) reporting increased
thirst that did not, in the short term, translate into largergains [27]. Also helpful in combating the problem of
excessive volume depletion is the routine use of volumet- interdialytic weight gains. Only one patient out of 10 did
not tolerate it well, becoming hypertensive with nausearic dialysis machines that are able to remove volume
evenly over the course of a dialysis. These machines and headache (mean arterial pressure postdialysis 122
mm Hg). Based on the results of this and other studiesmay be adjusted to remove disproportionate amounts of
volume at different times in the dialysis and thereby [18], our results support the use of a step-wise protocol
starting with the higher sodium dialysate at the beginningallow the physician to tailor the dialysis to an individual
patient’s tolerance. The use of sodium modeling proto- of dialysis.
Also effective in preventing hypotension was the usecols has become more popular in the last five years and
also is designed to maintain a stable plasma osmolality of a higher sodium dialysate and cooler temperature
dialysis. Excessive thirst may occur in some patients uponduring the course of ultrafiltration on dialysis. Several
recent studies have addressed the design of the sodium exposure to the higher sodium dialysate and is roughly
proportional to the concentration of dialysate sodiummodeling protocol and have suggested that the step-
wise design has advantages over linear and logarithmic employed. Cooler temperature dialysis is also tolerated
by most patients [19, 30, 31]; shivering and crampingsodium modeling [18]. In addition, the sodium modeling
studies have also supported the use of the higher sodium occur in some patients and limit use. In the present study,
7 of 10 patients noted a “cold” sensation, and shiveringdialysate at the beginning rather than at the conclusion
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9. Kinet JP, Soyeur D, Balland N, et al: Hemodynamic study ofwas seen in two patients. The use of isolated ultrafiltra-
hypotension during hemodialysis. Kidney Int 21:868–876, 1982
tion followed by dialysis was notably ineffective in this 10. Henrich WL, Woodard TD, Blachley JD, et al: Role of osmol-
study. As previously noted, isolated ultrafiltration may ality in blood pressure stability after dialysis and ultrafiltration.
Kidney Int 18:480–488, 1980be more effective in patients who have a smaller weight
11. Rouby JJ, Rotembourg J, Durande JP, et al: Importance of the
loss requirement during the procedure. It is interesting plasma refilling rate in the genesis of hypovolemic hypotension
to note that the majority (8 of 10) of hypotension-prone during regular dialysis and controlled sequential ultrafiltration he-
modialysis. Proc Eur Dial Transplant Assoc 15:239–244, 1978patients in this study were diabetics, which is not surpris-
12. Kooman JP, Gladziwa U, Bocker G, et al: Role of the venousing given the high prevalence of diabetes as an etiology of system in hemodynamics during ultrafiltration and bicarbonate
end-stage renal disease and the frequency of autonomic dialysis. Kidney Int 42:718–726, 1992
13. Poldermans D, Veld AJ, Rambaldi R, et al: Cardiac evaluationdisorders in this group of patients. We surmise that these
in hypotension-prone and hypotension-resistant hemodialysis pa-maneuvers will be efficacious in nondiabetic hypotension- tients. Kidney Int 56:1905–1911, 1999
prone patients as well, but this will require further testing. 14. Maynard JC, Cruz C, Kleerekoper M, et al: Blood pressure
response to changes in serum ionized calcium during hemodialysis.In summary, our study supports the use of sodium mod-
Ann Intern Med 104:358–361, 1986eling and cooler temperature dialysis as first options in 15. Henrich WL, Hunt JM, Nixon JV: Increased ionized calcium and
treating hypotension-prone patients; a higher sodium di- left ventricular contractility during hemodialysis. N Engl J Med
310:19–23, 1984alysate is also a reasonable therapeutic option. The use
16. Beasley D, Brenner BM: Role of nitric oxide in hemodialysisof midodrine as an adjunctive modality is also rational in hypotension. Kidney Int 42(Suppl 38):S96–S100, 1992
patients with repeated bouts of dialysis hypotension [32]. 17. Van Stone JC, Bauer J, Carey J: The effect of dialysate sodium
concentration on body fluid distribution during hemodialysis. TransFinally, the current study did not address the therapeutic
Am Soc Artif Intern Organs 26:383–386, 1980efficacy of combinations of these maneuvers. The rig- 18. Sadowski RH, Allred E, Jabs K: Sodium modelling ameliorates
orous testing of several combination maneuvers would dialytic and interdialytic symptoms in young hemodialysis patients.
J Am Soc Nephrol 4:1192–1198, 1993be of interest and is meritorious of future investigation.
19. Jost CM, Agarwal R, Khair-el-din T, et al: Effect of cooler
temperature dialysate on hemodynamic stability in “problem” dial-
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